Self-assembling cyclic systems as drug carriers

Self-assembling cyclic systems have been of interest to researchers for over a decade now, and their wide variety applications have been explored from electronic devices to medicinal purposes. But still their discovery for newer innovative applications remains as valuable as before. In this study, ab initio Hartree–Fock molecular orbital calculations have been performed on peptidic and peptidomimetic cyclic compounds to identify characteristics required in compounds for efficient self-aggregation. The effect of these characteristics in determining the pore size and length of nanotube has been studied. Effect of backbone and substituents on environment of outer and inner surface and carriage properties has been studied in detail. Self-aggregating compounds (Ala)12 and (Ala)10 have been predicted to form a tubular structure with dimensions in nanoscale. They have been predicted to work as novel drug carriers having inert outer wall and inner pore. A peptidic self-aggregating compound (Ala)12 has been studied and suggested as carrier for antibiotic gentamicin to exemplify carriage properties of the designed compound. Such novel self-aggregatory systems are expected to help simplify the drug delivery process and increase bioavailability of various drugs.